Skip to contentHome page Seeking Alpha - Power to InvestorsTranscriptsMar 20, 2026, 8:22 PM ETDenali Therapeutics Inc. (DNLI) StockSA Transcripts159.07K FollowersCommentsDenali Therapeutics Inc. (DNLI) Stifel 2026 Virtual CNS Forum March 17, 2026 2:00 PM EDTCompany ParticipantsRyan Watts - Co-Founder, President, CEO & DirectorConference Call ParticipantsPaul Matteis - Stifel Nicolaus Canada Inc., Research DivisionPresentationPaul MatteisStifel Nicolaus Canada Inc., Research DivisionGreat. Thanks, everybody, for continuing on here. It's my pleasure to be moderating a chat with Ryan Watts, Founder and CEO of Denali. I'm sure most folks know the story decently well. But maybe, Ryan, you can just give us a couple of minutes to sort of set the stage on 2026 is a big year for Denali with Hunter and the pipeline, and then we'll do Q&A. So thanks again.Ryan WattsCo-Founder, President, CEO & DirectorSounds great, Paul. Great to be here again. I was trying to count how many CNS days this is for me, but probably...Paul MatteisStifel Nicolaus Canada Inc., Research Division6 or 7. Do you know the first one was not on video. Well, no, I've done 7. The first one for you was probably 6 years ago, audio-only 5 days into COVID.Ryan WattsCo-Founder, President, CEO & DirectorYes. I remember that.Paul MatteisStifel Nicolaus Canada Inc., Research DivisionCrazy. So thank you. Appreciate it.Ryan WattsCo-Founder, President, CEO & DirectorIt's good to be back. And I think that might have even been a panel, if I recall, back...Paul MatteisStifel Nicolaus Canada Inc., Research DivisionYes, that was interesting. We can talk about that another time. That was interesting.Ryan WattsCo-Founder, President, CEO & DirectorI mean, 2026 is set up to be a very important year for Denali. I mean, obviously, we're at the very final stages of our first approval for tividenofusp alfa in Hunter syndrome. I think notRead more current DNLI analysis and newsView all earnings call transcriptsComments